Andrew Woolston

Genomic and Transcriptomic Determinants of Therapy Resistance and Immune Landscape Evolution during Anti-EGFR Treatment in Colorectal Cancer

Andrew Woolston, Khurum Khan, Georgia Spain et al. · Cancer Cell · 2019 · 262 citations · Full text

Medicine, Cancer Biology, Oncology +17

Resolving inequalities in care? Reduced mortality in the elderly after acute coronary syndromes. The Myocardial Ischaemia National Audit Project 2003-2010

Chris P Gale, Brian A. Cattle, Andrew Woolston et al. · European Heart Journal · 2011 · 199 citations · Full text

Medicine, Cardiology, Geriatric Medicine +17

Immunopeptidomics of colorectal cancer organoids reveals a sparse HLA class I neoantigen landscape and no increase in neoantigens with interferon or MEK-inhibitor treatment

Alice Newey, B Griffiths, Justine Michaux et al. · Journal for ImmunoTherapy of Cancer · 2019 · 144 citations · Full text

Medicine, Immunology, Oncology +17

CEA expression heterogeneity and plasticity confer resistance to the CEA-targeting bispecific immunotherapy antibody cibisatamab (CEA-TCB) in patient-derived colorectal cancer organoids

Reyes Gonzalez-Exposito, Maria Semiannikova, B Griffiths et al. · Journal for ImmunoTherapy of Cancer · 2019 · 115 citations · Full text

Life Sciences, Immunology, Oncology +17

Do bone grafts or barrier membranes provide additional treatment effects for infrabony lesions treated with enamel matrix derivatives? A network meta‐analysis of randomized‐controlled trials

Yu‐Kang Tu, Andrew Woolston, Clóvis Mariano Faggion · Journal Of Clinical Periodontology · 2009 · 86 citations · Full text

Dentistry, Periodontics, Periodontology +15